Ibrutinib-MPEA

MedChem Express

Ibrutinib-MPEA [1710768-30-1]

10

1710768-30-1

Research Use Only

99.71

C32H39N9O2

581.71

Ibrutinib-MPEA (Compound 20) is ibrutinib derivative. Ibrutinib is a covalent and irreversible inhibitor of Brutons tyrosine kinase (BTK) that has been used to treat haematological malignancies [1] .

NCCN1CCN(C/C=C/C(N2C[C@H](N3N=C(C4=CC=C(OC5=CC=CC=C5)C=C4)C6=C(N)N=CN=C63)CCC2)=O)CC1

-20°C,2°C to 8°C

12352200